EP 1267877 A1 20030102 - USE OF PYRIDO 3,2-E -PYRAZINONES AS INHIBITORS OF PHOSPHODIESTERASE 5 FOR TREATING ERECTILE DYSFUNCTION
Title (en)
USE OF PYRIDO 3,2-E -PYRAZINONES AS INHIBITORS OF PHOSPHODIESTERASE 5 FOR TREATING ERECTILE DYSFUNCTION
Title (de)
VERWENDUNG VON PYRIDO 3,2-e -PYRAZINONEN ALS INHIBITOREN DER PHOSPHODIESTERASE 5 ZUR THERAPIE VON EREKTILER DYSFUNKTION
Title (fr)
UTILISATION DE PYRIDO 3,2-E -PYRAZINONES COMME INHIBITEURS DE PHOSPHODIESTERASE 5 POUR TRAITER LE DYSFONCTIONNEMENT DE L'ERECTION
Publication
Application
Priority
- DE 10012373 A 20000314
- EP 0102485 W 20010306
Abstract (en)
[origin: WO0168097A1] The invention relates to the use of pyrido[3,2-e]-pyrazinones of formula (1) as inhibitors of phosphodiesterase 5 for treating erectile dysfunction (impotence).
IPC 1-7
IPC 8 full level
A61K 31/4985 (2006.01); A61P 15/10 (2006.01); C07D 471/14 (2006.01)
CPC (source: EP)
A61K 31/4985 (2013.01); A61P 15/10 (2017.12); C07D 471/14 (2013.01)
Citation (search report)
See references of WO 0168097A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated extension state (EPC)
LT LV MK RO SI
DOCDB simple family (publication)
WO 0168097 A1 20010920; AR 028250 A1 20030430; AU 4419201 A 20010924; BG 107077 A 20030530; BR 0109163 A 20021126; CZ 20023078 A3 20030312; DE 10012373 A1 20010920; EP 1267877 A1 20030102; HU P0300551 A2 20030728; IL 151646 A0 20030410; JP 2003528056 A 20030924; NO 20024364 D0 20020912; NO 20024364 L 20020927; RU 2002127413 A 20040227; SK 13232002 A3 20030502
DOCDB simple family (application)
EP 0102485 W 20010306; AR P010101174 A 20010313; AU 4419201 A 20010306; BG 10707702 A 20020910; BR 0109163 A 20010306; CZ 20023078 A 20010306; DE 10012373 A 20000314; EP 01917067 A 20010306; HU P0300551 A 20010306; IL 15164601 A 20010306; JP 2001566661 A 20010306; NO 20024364 A 20020912; RU 2002127413 A 20010306; SK 13232002 A 20010306